Oestrogen Patch May Cut Alzheimer’s Risk in Some Women

PhotoCredit:istock Administering the primary female sex hormone oestrogen via a skin patch shortly after menopause may reduce Alzheimer’s risk in women, suggests new research. The study, published in the Journal of Alzheimer’s Disease, found that newly postmenopausal women who received oestrogen via a skin patch had reduced beta-amyloid deposits, the sticky plaques found in the brains of people with Alzheimer’s disease. “This study showed, for the first time, that the brain amyloid deposition — a hallmark of Alzheimer’s disease — is reduced in newly postmenopausal women who received 17beta-Estradiol patch…

Read More

Oestrogen patch may cut Alzheimer’s risk in some women

Administering the primary female sex hormone oestrogen via a skin patch shortly after menopause may reduce Alzheimer’s risk in women, suggests new research. The study, published in the Journal of Alzheimer’s Disease, found that newly postmenopausal women who received oestrogen via a skin patch had reduced beta-amyloid deposits, the sticky plaques found in the brains of people with Alzheimer’s disease. “This study showed, for the first time, that the brain amyloid deposition — a hallmark of Alzheimer’s disease — is reduced in newly postmenopausal women who received 17beta-Estradiol patch form…

Read More

Oestrogen patch may cut Alzheimer’s risk in some women

Administering the primary female sex hormone oestrogen via a skin patch shortly after menopause may reduce Alzheimer’s risk in women, suggests new research. The study, published in the Journal of Alzheimer’s Disease, found that newly postmenopausal women who received oestrogen via a skin patch had reduced beta-amyloid deposits, the sticky plaques found in the brains of people with Alzheimer’s disease. “This study showed, for the first time, that the brain amyloid deposition — a hallmark of Alzheimer’s disease — is reduced in newly postmenopausal women who received 17beta-Estradiol patch form…

Read More